Abstract
A new derivative of 3,7-diazabicyclo[3.3.1]nonane, which showed a high activity as a positive allosteric modulator of AMPA receptors of the CNS, was studied in electrophysiological experiments. At doses of 0.01 mg/kg, this compound significantly improved the memory of experimental animals disturbed by maximal electric shock. The results indicate that this compound is a promising candidate for preclinical trials and clinical studies as a drug for treatment of a number of psychoneurological diseases.
Similar content being viewed by others
REFERENCES
Traynelis, S.F., Wollmuth, L.P., McBain, C.J., Menniti, F.S., Vance, K.M., Ogden, K.K., Hansen, K.B., Yuan, H., Myers, S.J., and Dingledine, R., Pharmacol. Rev., 2010, vol. 62, pp. 405–496.
Adler, L.A., Kroon, R.A., Stein, M., Shahid, M., Tarazi, F.I., Szegedi, A., Schipper, J., and Cazorla, P., Biol. Psychiatry, 2012, vol. 72, no. 11, pp. 971–977.
Lauterborn, J.C., Palmer, L.C., Jia, Y., Pham, D.T., Hou, B., Wang, W., Trieu, B.H., Cox, C.D., Kantorovich, S., Gall, C.M., and Lynch, G., J. Neurosci., 2016, vol. 36, no. 5, pp. 1636–1646.
Grigor'ev, V.V., Proshin, A.N., Kinzirskii, A.S., and Bachurin, S.O., Usp. Khim., 2009, vol. 78, no. 5, pp. 524–534.
Bachurin, S.O., Bovina, E.V., and Ustyugov, A.A., Med. Res. Rev., 2017, vol. 37, no. 5, pp. 1186–1225.
O'Neill, M.J., Bleakman, D., Zimmerman, D.M., and Nisenbaum, E.S., Curr. Drug Targets. CNS Neurol. Dis., vol. 3, no. 3, pp. 181–194.
Hu, X., Tian, X., Guo, X., He, Y., Chen, H., Zhou, J., and Wang, Z.J., Neuropharmacology, 2018, vol. 137, pp. 50–58.
Lavrov, M.I., Grigor’ev, V.V., Bachurin, S.O., Palyulin, V.A., and Zefirov, N.S., Dokl. Biochem. Biophys., 2015, vol. 464, no. 5, pp. 626–628.
Perlovich, G.L., Proshin, A.N., Volkova, T.V., Petrova, L.N., and Bachurin, S.O., Mol. Pharm., 2012, vol. 9, no. 8, pp. P. 2156–2167.
Voronina, T.A., Ostrovskaya, R.U., and Garibova, T.L., Rukovodstvo po provedeniyu doklinicheskikh issledovany lekarstvennykh sredstv (Guidelines for Preclinical Trials of Drugs), Moscow: FGBU NTsEMSP Minzdravsotsrazvitiya Rossii, 2012, part 1, pp. 276–297.
ACKNOWLEDGMENTS
In this study, we used the equipment of the Core Facility of the Institute of Physiologically Active Compounds, Russian Academy of Sciences (Agreement no. 14.621.21.0008, study ID RFMEFI62114X0008).
Funding
This study was supported by the State Assignment of the Institute of Physiologically Active Compounds, Russian Academy of Sciences (theme “The Search for and Study of the Mechanisms of Action of Neuroprotective Agents and Cognitive Stimulants,” state registration no. 0090-2017-0019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests. The authors declare that they have no conflict of interest.
Statement on the welfare of animals. All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
Additional information
Translated by M. Batrukova
Rights and permissions
About this article
Cite this article
Grigoriev, V.V., Lavrov, M.I., Zamoyski, V.L. et al. New Positive Allosteric Modulator of AMPA Receptors: in vitro and in vivo Studies. Dokl Biochem Biophys 488, 304–306 (2019). https://doi.org/10.1134/S160767291905003X
Published:
Issue Date:
DOI: https://doi.org/10.1134/S160767291905003X